# Acknowledgments



The ChEMBL resources are made available due to funding from the following:

#### Current Awards

* **2014-2019:** Wellcome Trust \(Strategic Award WT086151/Z/08/Z\). The member states of EMBL
* **2016-2022:** European Commission Horizon 2020. Toxicity Testing and Risk Assessment in the 21st Century EU-ToxRisk \(681002\)
* **2015:** Coordinated Research Infrastructures Building Enduring Life-science Services CORBEL \(654248\)
* **2014-2016:** Illuminating the Druggable Genome NIH grant 1U54CA189205-01
* **2014-2017:** The Center for Therapeutic Target Validation \(CTTV008\)
* **2013-2018:** European Commission FP7 HeCaTos - Safety prediction \(602156\)
* **2009-2016:** European Commission/IMI IMI eTox \(115002\)

#### Past Awards

* **2008-2014:** Chemogenomics at the EBI, WT Strategic award 086151/Z/08/Z
* **2012-2015:** European Commission FP7 BioMedBridges \(284209\)
* **2014-2014:** Pistoia Alliance Application of HELM Nomenclature to ChEMBL peptide content.
* **2012-2014:** Medicines for Malaria Ventures - Malaria Data Deposition Portal
* **2012-2014:** European Commission/IMI IMI Open PHACTS \(115191\)
* **2011-2014:** European Commission FP7 DiXa \(283775\)
* **2011-2014:** BBSRC/EPSRC/MRC SMSDrug.net - Chemical Biology Networking \(EP/I037229/1\)
* **2013-2013:** Syngenta - Herbicide and Insecticide Data for ChEMBL
* **2011-2013:** GSK - ADMET SARfari
* **2009-2013:** European Commission ESFRI EU-OpenScreen \(261861\)
* **2010-2011:** Pfizer - Druggability Analysis

